Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AI-assisted Lifestyle vs Tirzepatide for Weight Loss Maintenance in T2D
NCT07555730Phase 4Not yet recruiting
- Sponsor
- Huazhong University of Science and Technology
- Start
- Apr 2026
- Primary completion
- Sep 2028
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in type 2 diabetes mellitus (T2DM), obesity, sponsored by Huazhong University of Science and Technology. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT07555730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07555730.